Tiracizine

Tiracizine is an antiarrhythmic agent also known as cardiac dysrhythmia medications, are a group of pharmaceuticals that are used to suppress abnormally fast rhythms (tachycardias), such as atrial fibrillation, supraventricular tachycardia and ventricular tachycardia.

Tiracizine was a medication intended to treat irregular heartbeats (arrhythmias). However, it's important to know that it's no longer in use due to safety concerns. Here's what we can tell you about Tiracizine:

Function:

• Class Ia Antiarrhythmic: Tiracizine belonged to a class of drugs known as class Ia antiarrhythmics. These medications worked by affecting the electrical activity of the heart to regulate its rhythm.

History:

• Withdrawn from Market: Tiracizine was withdrawn from the market in 1994 after studies in mice showed an increased risk of tumors at high doses. While a direct link to humans wasn't established, the potential risk outweighed the benefits.
• Limited Use: It's important to note that Tiracizine wasn't even widely available. It was primarily used in Germany and exported to a few other Eastern European countries, but never approved in the United States or many other Western nations.